COMPANY

Expertise with Responsibility – Shaping Health Together

We are a family-owned company and feel responsible for our customers, suppliers, employees and our society as a matter of course. 

As experts for soft-gel capsules we make complex compositions possible at a modern, high quality production level.

Our aim is with our activities, products and services to support and care for people’s health.

OUR MAIN PRINCIPLES

Quality

The realization of our quality and product policy is one important task of the leading manager ́s. “Our General Manager ́s task.”

CUSTOMER´S REQUEST

To fully meet our customer´s requrements, individual and short-term, is part of our expectations as a modern company in a fast shifting society.

LOYALTY

We are convinced that the best results can be reached through loyal and long-term partnerships.

Responsibility

We feel responsible for our customers and employees. Respect, expactatious and mutual assistance are an important part of our company´s philosophy.

Public health

The responsibility towards our society is not only based in our core business but we feel obliged to support ideas contributing to the general health.

1959

Foundation of A.R.C.O. – CHEMIE GmbH
by Arthur Loose and Cornelius Souvereinn.

1961

Take over by the Zirkulin Werke GmbH.

1962

Authorization to produce drugs acc. to §1 chapt. 1;
Manufacturing of drugs, dietical products and nutritional supplements.

1984

Sale of the Zirkulin Werke GmbH to the ROHA Arzneimittel GmbH & Co. KG

Purchase of A.R.C.O.®-Chemie GmbH by the long-standing Head of Manufacturing Georgios Zacharopoulos.

1986

WHO-GMP approval.

1989 - 1991

First extension of our plant.

1997 – 1999

Further extension of the production plant.

2006

Expansion into new international markets.

2010

New scope of service implementation (CDMO approach), presenting ready to market products launch of ARCOMPETENCE.

2014

Step in of 2nd generation:
Konstantinos and Alexandros Zacharopoulos ensuring of independent family business.

2018

Implementation of track and trace (serialization) for prescription medications.

2022 – 2023

Further capacity expansion (30%) of finished products and softgel encapsulation.